Procaps Group, a healthcare and pharmaceutical conglomerate, has bought Grupo Somar, a pharmaceutical firm, from Advent International, a private equity investor.

Grupo Somar offers a range of products and has R&D and manufacturing expertise, with six production facilities.

“We believe Procaps is a very good harbor where Grupo Somar and its management team will continue to grow, developing new products both in Mexico and LatAm,” said Juan Pablo Zucchini, a managing partner at Advent International.

Morgan Stanley & Co. LLC served as exclusive financial advisor and Greenberg Traurig served as legal counsel to Procaps.